Valuation ResMed, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 17:34:06 18/06/2026 BST			5-day change	1st Jan Change
188.04 ^USD	+0.94%		-2.53%	-22.15%

06-17	ResMed Shares Fall After Morgan Stanley Downgrade	MT
06-17	Morgan Stanley Downgrades ResMed to Equalweight From Overweight, Adjusts PT to $230 From $286	MT

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	35,903	30,691	32,133	28,117	37,762	26,904	-	-
Change	-	-14.52%	4.7%	-12.5%	34.31%	-28.75%	-	-
Enterprise Value (EV) ¹	36,263	31,192	33,346	28,585	37,221	26,045	25,327	24,348
Change	-	-13.98%	6.9%	-14.28%	30.21%	-30.03%	-2.76%	-3.86%
P/E	76.1x	39.6x	35.9x	27.7x	27.1x	17.6x	15.9x	14.7x
PBR	12.4x	9.35x	7.76x	5.78x	6.33x	4.13x	3.83x	3.55x
PEG	-	0.6x	2.4x	2x	0.7x	1.5x	1.5x	1.86x
Capitalization / Revenue	11.2x	8.58x	7.61x	6x	7.34x	4.76x	4.41x	4.13x
EV / Revenue	11.3x	8.72x	7.9x	6.1x	7.23x	4.61x	4.15x	3.73x
EV / EBITDA	33.8x	26.8x	25.3x	18.1x	19.8x	11.9x	10.6x	9.49x
EV / EBIT	40.1x	31.2x	27.2x	19.3x	21.1x	12.8x	11.4x	10.1x
EV / FCF	57.2x	144x	58.1x	22x	22.4x	16.1x	15x	13.6x
FCF Yield	1.75%	0.69%	1.72%	4.55%	4.46%	6.21%	6.65%	7.35%
Dividend per Share ²	1.56	1.68	1.8	1.92	2.12	2.43	2.689	2.962
Rate of return	0.63%	0.8%	0.82%	1%	0.82%	1.3%	1.44%	1.59%
EPS ²	3.24	5.3	6.09	6.92	9.51	10.6	11.71	12.63
Distribution rate	48.1%	31.7%	29.6%	27.7%	22.3%	22.9%	23%	23.5%
Net sales ¹	3,197	3,578	4,223	4,685	5,146	5,651	6,096	6,519
EBITDA ¹	1,074	1,162	1,317	1,576	1,884	2,190	2,379	2,565
EBIT ¹	903.7	1,000	1,224	1,478	1,763	2,035	2,214	2,400
Net income ¹	474.5	779.4	897.6	1,021	1,401	1,549	1,701	1,852
Net Debt ¹	360.1	501.5	1,213	468.9	-541.2	-859.1	-1,578	-2,556
Reference price ²	246.52	209.63	218.50	191.42	258.00	186.29	186.29	186.29
Nbr of stocks (in thousands)	145,640	146,405	147,062	146,884	146,365	144,421	-	-
Announcement Date	05/08/21	11/08/22	03/08/23	01/08/24	31/07/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
RESMED, INC.	17.58x	4.61x	11.89x	1.3%	26.9B
THERMO FISHER SCIENTIFIC, INC.	23.12x	4.24x	16.34x	0.4%	172B
INTUITIVE SURGICAL, INC.	44.17x	11.56x	25.87x	-.--%	142B
DANAHER CORPORATION	28.37x	-	-	0.81%	126B
BOSTON SCIENTIFIC CORPORATION	16.46x	3.41x	10.98x	-.--%	66.81B
EDWARDS LIFESCIENCES CORPORATION	30.91x	6.88x	21.88x	-.--%	49.91B
SIEMENS HEALTHINEERS AG	18.3x	2.11x	10.79x	2.89%	44.81B
AGILENT TECHNOLOGIES, INC.	24.15x	4.82x	16.61x	0.83%	35.11B
WATERS CORPORATION	43.27x	6.09x	18.75x	-.--%	35.05B
GE HEALTHCARE TECHNOLOGIES INC.	13.63x	1.55x	8.67x	0.25%	27.82B
Average	26.00x	5.03x	15.75x	0.65%	72.62B
Weighted average by Cap.	28.24x	5.98x	17.65x	0.51%